Menu
Back to Journals » Cancer Management and Research » Volume 11
Review
Beyond Ruxolitinib: Fedratinib and Other Emergent Treatment Options for Myelofibrosis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,061 | Dovepress* | 8,540+ | 1,592 | 10,132 | |
| PubMed Central* | 5,521 | 962 | 6,483 | ||
| Totals | 14,061 | 2,554 | 16,615 | ||
| *Since 24 December 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 2 | 3 |
View citations on PubMed Central and Google Scholar